August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 26, 2025

Rituximab Linked to Weakened COVID-19 Immunity

Rituximab-treated patients with rheumatic disease had diminished antibody levels and impaired CD8+ T-cell responses after SARS-CoV-2 infection and vaccination, though CD4+ responses remained intact.

Conexiant

August 05, 2025

Cannabis Use Common Among Adolescents With Chronic Pain, Study Finds

Researchers found that one in four adolescents with chronic pain reported lifetime cannabis use.

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

March 04, 2025

FDA Approves Prefilled Syringe for Cortrophin Gel

FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.

Conexiant

December 16, 2024

Arthritis Drugs Linked to Fracture Risk

Current gabapentinoid use in patients with inflammatory arthritis was associated with a 36% higher odds of fractures compared to remote use, with risks persisting across most dose levels and showing marked impact shortly after drug initiation.

Conexiant